β-Adrenergic Receptor Blockers in Hypertension
نویسندگان
چکیده
منابع مشابه
β blockers in hypertension and cardiovascular disease
β blockers are useful in managing angina and reducing mortality after myocardial infarction and in heart failure. They probably reduce cardiovascular events in high risk surgery and retard the progression of atherosclerosis. In younger patients, β blockers should remain first line antihypertensives, together with diuretics, calcium channel blockers, angiotensin converting enzymes, and adrenergi...
متن کاملAre adrenergic receptor blockers effective or contraindicated in pulmonary arterial hypertension?
ulmonary arterial hypertension (PAH) is a life-threatening disease characterized by progressively elevated pulmonary vascular resistance. Sustained elevation of pulmonary vascular resistance causes severe right ventricular (RV) hypertrophy and failure accompanied by severely reduced cardiac output and leads to poor prognosis. Treatment with vasodilators, such as epoprostenol (prostaglandin I2),...
متن کاملAngiotensin receptor blockers: baseline therapy in hypertension?
The provocative editorial by Verma and Strauss in the BMJ 5 years ago stating that angiotensin receptor blockers (ARBs) ‘may increase myocardial infarction—and patients may need to be told’ caused a tempest in the teapot and led to extensive scrutiny of outcome data with this drug class. In 2007 the blood pressurelowering treatment trialists collaboration found that there were similar blood pre...
متن کاملDoes atenolol differ from other β-adrenergic blockers?
BACKGROUND A recent meta-analysis of drug effects in patients with hypertension claims that all beta-adrenergic blockers are equally effective but less so than other antihypertensive drugs. Published comparisons of the beta-adrenergic blocker atenolol and non-atenolol beta-adrenergic blockers indicate different effects on death rates, arrhythmias, peripheral vascular resistance and prognosis po...
متن کاملThe role of beta-adrenergic receptor blockers in autism
β-adrenergic receptor blockade has been demonstrated to benefit individuals with autism. Genetic studies have identified numerous factors linking β-adrenergic receptor blockade to autism spectrum disorder (ASD), including βadrenergic receptor variants, human leukocyte antigen genes, apoptotics factor caspase-3, glycogen synthetase kinase-3β, and the reduced form of nicotinamide adenine dinucleo...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Journal of Cardiology
سال: 2014
ISSN: 0828-282X
DOI: 10.1016/j.cjca.2014.02.015